E. Nicastri, N. Petrosillo, Tommaso Ascoli Bartoli, L. Lepore, A. Mondi, F. Palmieri, G. D'Offizi, L. Marchioni, S. Murachelli, G. Ippolito, A. Antinori
2020.2.25Infectious Disease Reports
tlooto Summary
Recommendations for the management of COVID-19 patients are shown, based on very limited clinical evidences, which should be considered as expert opinions, which may be modified according to newly produced literature data.
Abstract
On January 9 2020, the World Health Organization (WHO) declared the identification, by Chinese Health authorities, of a novel coronavirus, further classified as SARS-CoV-2 responsible of a disease (COVID-19) ranging from asymptomatic cases to severe respiratory involvement. On March 9 2020, WHO declared COVID-19 a global pandemic. Italy is the second most affected country by COVID-19 infection after China. The “L. Spallanzani” National Institute for the Infectious Diseases, IRCCS, Rome, Italy, has been the first Italian hospital to admit and manage patients affected by COVID-19. Hereby, we show our recommendations for the management of COVID-19 patients, based on very limited clinical evidences; they should be considered as expert opinions, which may be modified according to newly produced literature data.
Citation format
NICASTRI, E., et al. National institute for the infectious diseases “l. spallanzani”, IRCCS. recommendations for COVID-19 clinical management. Infectious Disease Reports, 2020, 12.